Donaldson (NYSE:DCI) Surprises With Q1 CY2026 Sales

Donaldson (NYSE:DCI) reported Q1 CY2026 sales of $995.1 million, up 5.9% year on year, exceeding Wall Street’s revenue estimate by 1.6%, according to the article. Non-GAAP adjusted EPS was $1.06, up from $0.99, and beat consensus by 1.2%. The stock rose 4.9% to $85.76 after the release.

Original reporting
Published Jun 2, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 1:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Donaldson (NYSE:DCI) Surprises With Q1 CY2026 Sales — source image
Decision brief

The 30-second read

$DCIBullishMed
01

Why it matters

Q1 beat plus operating margin expansion is the immediate catalyst; however, the forward revenue growth outlook described as similar to the slower two-year rate may temper longer-horizon enthusiasm.

02

Market read

Material single-name earnings-style datapoints (revenue, adjusted EPS, margin) with an explicit immediate price reaction and a forward growth expectation that is not strong.

03

What to watch

Forward EPS consensus data is described as insufficient, so traders may be underpricing uncertainty in earnings trajectory beyond the reported quarter.

Relevance 9/10Novelty 8/10Timing: immediately after Q1 release (shares up 4.9% to $85.76)

Background

The piece frames Donaldson’s Q1 CY2026 results versus both Wall Street expectations and longer-term revenue/EPS trends, including constant-currency growth and operating margin drivers.

Company-level read

Ticker impact

$DCIBullishMedium confidence
Context

Donaldson reported Q1 CY2026 revenue of $995.1M (+5.9% YoY) and adjusted EPS $1.06, both beating consensus, sending shares up 4.9% to $85.76.

Expected impact

Likely short-term upside bias/volatility after the earnings beat, with upside capped by the article’s underwhelming 12-month revenue growth outlook.

Evidence & confidence

The article provides fresh, time-sensitive Q1 results and immediate post-report price reaction, but it also highlights decelerating longer-term growth and only modest next-12-month expectations.

Market effects

Supports the industrial filtration/engineered components complex as investors reward margin resilience despite slower topline growth.

No explicit regional drivers cited; impact likely US-focused via the NYSE-listed name.

Constant-currency commentary suggests FX was not a key driver, implying underlying demand rather than currency tailwinds.

Counterpoint

The article flags decelerating growth (two-year revenue growth 3.8% annualized) and a modest 3.9% expected next-12-month revenue growth, which could limit follow-through after the initial beat.

Key entities

  • Donaldson

    Filtration equipment manufacturer; subject of the Q1 CY2026 sales and adjusted EPS beat and the post-report stock move.

Related articles

$DCIMedAI 9/10

Donaldson Q3 Earnings Call Highlights

Donaldson reported Q3 updates across segments. Mobile Solutions off-road sales rose 9% to $104M and on-road 5% to $28M; China Mobile Solutions sales grew 6%, led by off-road. Life Sciences sales rose 13% to $84M. Industrial Solutions sales fell 1% to $282M; Aerospace & Defense fell 14% to $45M. CFO Brad Pogalz said Industrial Solutions pretax margin was 13.4% vs 18.1% a year ago. For FY2026, organic sales growth guidance is 3%–5% (midpoint raised), with organic operating margin 15.8%–16.2% and a

$DCIMedAI 9/10

Donaldson Co Inc (DCI) Q3 2026 Earnings Call Highlights: Record Sales and Strategic Wins Amidst...

Donaldson’s Q3 2026 earnings call said the Industrial business expects margins to return to about 18% by the midpoint of fiscal 2027, helped by footprint optimization and Power Generation ramp-up, with an additional $10 million savings expected absent major mix changes. The Facet Filtration integration targets $4–5 million procurement synergies. CFO Brad Pogalz cited improved operations, volumes, and plant closures for Q4 margin gains. Aerospace/Defense ended Q3 with near-record backlogs, though

$DCIMedAI 9/10

Benzinga

Donaldson (NYSE:DCI) reported third-quarter results with record sales of $995 million, up 6% year over year, driven by currency translation, net pricing benefits, and volume growth. Adjusted EPS was $1.06 and operating margin 16.6%. The company said it closed its Facet Filtration acquisition and revised fiscal 2026 organic sales growth guidance to 3%–5%.

$INTUMed

Dow Jones retreats on worries of valuation bubble, Nasdaq 'supported by FOMO'

US stocks opened slightly lower Tuesday: the Dow was down 0.4%, the S&P 500 down about 0.1%, and the Nasdaq near flat. The prior session closed at record highs. Analysts cited valuation “bubble” worries and “FOMO” after the Nasdaq’s 25% gain since late March. Sector moves included tech and energy higher; Intuit, Carvana and Trade Desk fell. Futures pointed to a softer open.

$DCIMedAI 9/10

Donaldson Narrows 2026 Guidance

Donaldson (DCI) narrowed 2026 guidance, forecasting Facet-related sales of $25m–$30m and net EPS dilution of about $0.03. Excluding Facet, organic adjusted EPS is expected at $3.94–$4.01 (+7%–9%), and organic sales to rise 3%–5% (vs 1%–5% prior). Q3 net earnings were $118.1m ($1.00 EPS) on $995.1m sales. Donaldson completed the $829m all-cash Facet Filtration acquisition on May 4, 2026.

$JANMedAI 8/10

JAN Q2 Earnings Call Highlights

Janus Living (NYSE:JAN) reported sequential same-store NOI margin down 40 bps, citing seasonality. Occupancy rose for independent living but fell for skilled nursing. The company acquired two communities for $105M, sold one for $23M, and completed $1B more acquisitions post-quarter. It raised 2026 FFO guidance to $0.95-$0.98 and same-store adjusted NOI growth to 13%-17%.